H.R. 4822 118th Congress
Health Care Price Transparency Act of 2023
Latest action, Sep 29, 2023: Reported (Amended) by the Committee on Ways and Means. H. Rept. 118-231, Part I.
How the House voted
The House hasn't taken a roll call on this bill in the Congresses covered.
Sponsor
Sponsored by Jason Smith (Republican). No cosponsors.
Referred to: House: Budget Committee; House: Education and Workforce Committee; House: Energy and Commerce Committee; House: Ways and Means Committee
Who lobbied on it
Clients whose quarterly lobbying reports named it, each quarter.
The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.
AMERICAN ACADEMY OF OPHTHALMOLOGY
CAPITOL COUNSEL LLC
6 reports
AMERICAN ACADEMY OF PHYSICAL MEDICINE AND REHABILITATION
6 reports
AMERICAN ASSOCIATION OF NURSE PRACTITIONERS
WHEAT SHROYER GOVERNMENT RELATIONS LLC
6 reports
6 reports
AMERICAN MEDICAL ASSOCIATION
LOPER CONSULTING LLC
6 reports
6 reports
AMGEN USA INC.
MARSHALL & POPP, LLC
6 reports
6 reports
6 reports
6 reports
6 reports
6 reports
The top 25 of 77 clients, by reports
| Client | Lobbying firm | Reports | Reports totaling | From | To | House |
|---|---|---|---|---|---|---|
| SOCIETY FOR CARDIOVASCULAR ANGIOGRAPHY AND INTERVENTIONS | 7 | $252K | Q4 2023 | Q3 2024 | yes | |
| AMERICAN ACADEMY OF OPHTHALMOLOGY | CAPITOL COUNSEL LLC | 6 | $0 | Q4 2023 | Q3 2024 | yes |
| AMERICAN ACADEMY OF PHYSICAL MEDICINE AND REHABILITATION | 6 | $140K | Q4 2023 | Q3 2024 | yes | |
| AMERICAN ASSOCIATION OF NURSE PRACTITIONERS | 6 | $2.3M | Q4 2023 | Q3 2024 | yes | |
| AMERICAN ASSOCIATION OF NURSE PRACTITIONERS | WHEAT SHROYER GOVERNMENT RELATIONS LLC | 6 | $0 | Q4 2023 | Q3 2024 | yes |
| AMERICAN COLLEGE OF PHYSICIAN SERVICES, INC. | 6 | $1.9M | Q4 2023 | Q3 2024 | yes | |
| AMERICAN COLLEGE OF PHYSICIANS | 6 | $671K | Q4 2023 | Q3 2024 | yes | |
| AMERICAN MEDICAL ASSOCIATION | LOPER CONSULTING LLC | 6 | $0 | Q4 2023 | Q3 2024 | yes |
| AMGEN INC | 6 | $18.1M | Q4 2023 | Q3 2024 | yes | |
| AMGEN USA INC. | MARSHALL & POPP, LLC | 6 | $0 | Q4 2023 | Q3 2024 | yes |
| ARTHRITIS FOUNDATION | 6 | $575K | Q4 2023 | Q3 2024 | yes | |
| BLUECROSS BLUESHIELD OF TENNESSEE | 6 | $1.6M | Q4 2023 | Q3 2024 | yes | |
| CALIFORNIA HOSPITAL ASSOCIATION | 6 | $2.3M | Q4 2023 | Q3 2024 | yes | |
| CAMBIA HEALTH SOLUTIONS | 6 | $3.7M | Q4 2023 | Q3 2024 | yes | |
| DANA-FARBER CANCER INSTITUTE | 6 | $424K | Q4 2023 | Q3 2024 | yes | |
| GENENTECH, INC. | MARSHALL & POPP, LLC | 6 | $0 | Q4 2023 | Q3 2024 | yes |
| GREATER NEW YORK HOSPITAL ASSOCIATION | 6 | $3.2M | Q4 2023 | Q3 2024 | yes | |
| HCA | THE SMITH-FREE GROUP, LLC | 6 | $480K | Q4 2023 | Q3 2024 | yes |
| HOSPITAL & HEALTHSYSTEM ASSOCIATION OF PENNSYLVANIA | 6 | $413K | Q4 2023 | Q3 2024 | yes | |
| INDEPENDENT PHARMACY COOPERATIVE | 6 | $300K | Q4 2023 | Q3 2024 | yes | |
| KAISER FOUNDATION HEALTH PLAN INC | 6 | $3.7M | Q4 2023 | Q3 2024 | yes | |
| NATIONWIDE CHILDREN'S HOSPITAL INC | 6 | $325K | Q4 2023 | Q3 2024 | yes | |
| PFIZER, INC. | MARSHALL & POPP, LLC | 6 | $0 | Q4 2023 | Q3 2024 | yes |
| PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION | RYAN COSTELLO STRATEGIES | 6 | $0 | Q4 2023 | Q3 2024 | yes |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | MARSHALL & POPP, LLC | 6 | $0 | Q4 2023 | Q3 2024 | yes |